GUABENXAN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C10H13N3O2
Molecular Weight	207.2291
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of GUABENXAN

Structure Search

SMILES

NC(=N)NCC1=CC=C2OCCOC2=C1

InChI

InChIKey=WTDYJDLUNYALPM-UHFFFAOYSA-N

InChI=1S/C10H13N3O2/c11-10(12)13-6-7-1-2-8-9(5-7)15-4-3-14-8/h1-2,5H,3-4,6H2,(H4,11,12,13)

HIDE SMILES / InChI

Molecular Formula	C10H13N3O2
Molecular Weight	207.2291
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6751915

Guabenxan was developed as an oral antihypertensive drug.

Approval Year

PubMed

PubMed

Title	Date	PubMed
[Double-blind controlled study of the therapeutic effectiveness and tolerance of the guabenxan-bemetizid combination as compared with guanethidine-hydrochlorothiazide in arterial hypertension in the aged].	1982-04	6751915

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:01:31 GMT 2025` Edited by `admin` on `Mon Mar 31 18:01:31 GMT 2025`
Record UNII	SAW16W26X6
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GUABENXAN

Official Name

English

GUABENXAN [MART.]

Preferred Name

English

(1,4-BENZODIOXAN-6-YLMETHYL)GUANIDINE

Systematic Name

English

guabenxan [INN]

Common Name

English

Guabenxan [WHO-DD]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C270

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

Code System Code Type Description

PUBCHEM

28563

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

INN

3544

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

SMS_ID

100000084259

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

NCI_THESAURUS

C65820

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

CAS

19889-45-3

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

DRUG CENTRAL

1332

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

FDA UNII

SAW16W26X6

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

MESH

C036327

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

EPA CompTox

DTXSID60173643

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

ChEMBL

CHEMBL2105111

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

EVMPD

SUB07967MIG

Created by admin on Mon Mar 31 18:01:31 GMT 2025 , Edited by admin on Mon Mar 31 18:01:31 GMT 2025

PRIMARY

Related Record Type Details


					SAW16W26X6

GUABENXAN

ACTIVE MOIETY